Unrestricted Ketogenic Diet Feeding Enhances Epithelial Ovarian Cancer Growth In Vivo
Authors:
- Mariam M. AlHilliMAMariam M. AlHilli
- Emily E. RhoadesEREmily E. Rhoades
- Danielle ChauDCDanielle Chau
- Surabhi TewariSTSurabhi Tewari
- Adrian ReichARAdrian Reich
- Alex MyersAMAlex Myers
- Daniel J. LindnerDLDaniel J. Lindner
- Justin D. LathiaJLJustin D. Lathia
- Renliang ZhangRZRenliang Zhang
- Belinda WillardBWBelinda Willard
- Gail CresciGCGail Cresci
- Nathan A. BergerNathan A. Berger
Open Access
Abstract
The ketogenic diet (KD) is hypothesized to impact tumor progression by altering tumor metabolism. In this study, we assessed the impact of an unrestricted KD on epithelial ovarian cancer (EOC) tumor growth, gene expression, and metabolite concentration in a mouse model. ID8 EOC cells, which were syngeneic with C57Bl/6J mouse strain and transfected with luciferase (ID8-luc), were injectedand monitored for tumor development. Female mice were fed either a strict KD, a high fat/low carbohydrate (HF/LC) diet, or a low fat/high carbohydrate (LF/HC) diet (n = 10 mice per group) ad libitum. EOC tumor growth was monitored weekly, and tumor burden was determined based on luciferase fluorescence (photons/second). At the endpoint (42 days), tumors were collected and processed for RNA sequencing. Plasma and tumor metabolites were evaluated using LC-MS. The KD-fed mice exhibited a statistically significant increase in tumor progression in comparison to the HF/LC- and LF/HC-fed groups (9.1 vs. 2.0 vs. 3.1-fold, respectively, p < 0.001). The EOC tumors of the KD-fed mice exhibited significant enrichment of the peroxisome proliferator-activated receptor (PPAR) signaling and fatty acid metabolism pathways based on the RNA sequencing analysis when compared to the LF/HC- and HF/LC-fed mice. Thus, unrestricted KD diet enhanced tumor progression in our mouse EOC model. KD was associated with the upregulation of fatty acid metabolism and regulation pathways, as well as enrichment of fatty acid and glutamine metabolites.Keywords
Funding Information
- the NIH K12CA076917 Clinical Oncology Training Program (5 P30 CA043703-3)
- the Case Comprehensive Cancer Center Athymic Animal and Preclinical Therapeutics Shared Resource and NCI core (5 P30 CA043703-3)
This publication has 52 references indexed in Scilit:
- Adipose tissue and adipocytes support tumorigenesis and metastasisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Emerging Roles of Angiopoietin-like 4 in Human CancerMolecular Cancer Research, 2012
- Dietary Restriction Promotes Vessel Maturation in a Mouse AstrocytomaJournal of Oncology, 2011
- Ketones and lactate “fuel” tumor growth and metastasisCell Cycle, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Ketone bodies inhibit the viability of human neuroblastoma cellsJournal of Pediatric Surgery, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Antiangiogenic and Proapoptotic Effects of Dietary Restriction on Experimental Mouse and Human Brain TumorsClinical Cancer Research, 2004
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003